Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-26 @ 3:44 PM
Study NCT ID:
NCT00879359
Status:
COMPLETED
Last Update Posted:
2017-04-26
First Post:
2009-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Sponsor:
The Cleveland Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-09
First Submit QC Date:
None
Study First Post Date:
2009-04-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-10
Results First Submit QC Date:
None
Results First Post Date:
2017-04-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-16
Last Update Post Date:
2017-04-26
Last Update Post Date Type:
ACTUAL